Circulating nucleic acids and protease activities in blood of tumor patients

Expert Opinion on Biological Therapy

Volumn 12, Issue SUPPL. 1, 2012, Pages

  Schwarzenbach, Heidi ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Cell free DNA; Cell free nucleosomes; Circulating caspase activities; Circulating protease activities

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CASPASE; CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 8; CYTOTOXIC AGENT; DNA; NUCLEIC ACID; PLASMA PROTEIN; PROTEINASE; TAXANE DERIVATIVE;

APOPTOSIS; BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INVASION; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CELL MIGRATION; CELL VIABILITY; CIRCULATING TUMOR CELL; COLORECTAL CANCER; CONFERENCE PAPER; DISTANT METASTASIS; DNA CLEAVAGE; DNA FRAGMENTATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; EPIGENETICS; HUMAN; LUNG CANCER; MACROPHAGE; METASTASIS; NEOPLASM; NUCLEOSOME; OVARY CANCER; PANCREAS CANCER; PATHOGENESIS; PHAGOCYTOSIS; TREATMENT RESPONSE; TUMOR CELL; TUMOR GROWTH;

CASPASES; DISEASE PROGRESSION; DNA; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; NUCLEIC ACIDS; PEPTIDE HYDROLASES;

EID: 84861441160     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2012.674508     Document Type: Conference Paper

References (52)

1. Pantel K, Brakenhoff RH. Dissecting the metastatic cascade. Nat Rev Cancer 2004; 4: 448-56 (Pubitemid 38745530)
2. Fleischhacker M, Schmidt B. Circulating nucleic acids (cnas) and cancer- A survey. Biochim Biophys Acta 2007; 1775: 181-232 (Pubitemid 44911084)
3. Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 2011; 11: 426-37
4. Holdenrieder S, Nagel D, Schalhorn A, et al. Clinical relevance of circulating nucleosomes in cancer. Ann NY Acad Sci 2008; 1137: 180-9
5. Stroun M, Lyautey J, Lederrey C, et al. About the possible origin and mechanism of circulating DNA apoptosis and active DNA release. Clin Chim Acta 2001; 313: 139-42 (Pubitemid 33016703)
6. Ward TH, Cummings J, Dean E, et al. Biomarkers of apoptosis. Br J Cancer 2008; 99: 841-6
7. Stollar BD, Stephenson F. Apoptosis and nucleosomes. Lupus 2002; 11: 787-9 (Pubitemid 36069972)
8. Choi JJ, Reich CF III, Pisetsky DS. The role of macrophages in the in vitro generation of extracellular DNA from apoptotic and necrotic cells. Immunology 2005; 115: 55-62 (Pubitemid 40593291)
9. Rumore P, Muralidhar B, Lin M, et al. Haemodialysis as a model for studying endogenous plasma DNA: oligonucleosome-like structure and clearance. Clin Exp Immunol 1992; 90: 56-62
10. Lopez-Otin C, Matrisian LM. Emerging roles of proteases in tumour suppression. Nat Rev Cancer 2007; 7: 800-8 (Pubitemid 47463671)
11. Pantel K, Alix-Panabieres C, Riethdorf S. Cancer micrometastases. Nat Rev Clin Oncol 2009; 6: 339-51
12. Mazar AP. Urokinase plasminogen activator receptor choreographs multiple ligand interactions: implications for tumor progression and therapy. Clin Cancer Res 2008; 14: 5649-55
13. Reimers N, Zafrakas K, Assmann V, et al. Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells. Clin Cancer Res 2004; 10: 3422-8 (Pubitemid 38685448)
14. Wimberger P, Roth C, Pantel K, et al. Impact of platinum-based chemotherapy on circulating nucleic acid levels, protease activities in blood and disseminated tumor cells in bone marrow of ovarian cancer patients. Int J Cancer 2011; 128: 2572-80
15. Schwarzenbach H, Alix-Panabieres C, Muller I, et al. Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer. Clin Cancer Res 2009; 15: 1032-8
16. Jahr S, Hentze H, Englisch S, et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 2001; 61: 1659-65 (Pubitemid 34292602)
17. Stroun M, Maurice P, Vasioukhin V, et al. The origin and mechanism of circulating DNA. Ann NY Acad Sci 2000; 906: 161-8 (Pubitemid 30255476)
18. Jung K, Fleischhacker M, Rabien A. Cell-free DNA in the blood as a solid tumor biomarker-a critical appraisal of the literature. Clin Chim Acta 2010; 411: 1611-24
19. Diehl F, Li M, Dressman D, et al. Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proc Natl Acad Sci USA 2005; 102: 16368-73 (Pubitemid 41688920)
20. Schwarzenbach H, Chun FK, Lange I, et al. Detection of tumor-specific DNA in blood and bone marrow plasma from patients with prostate cancer. Int J Cancer 2007; 120: 1465-71 (Pubitemid 46355381)
21. Ziegler A, Zangemeister-Wittke U, Stahel RA. Circulating DNA: a new diagnostic gold mine? Cancer Treat Rev 2002; 28: 255-71 (Pubitemid 35439439)
22. Lee TH, Montalvo L, Chrebtow V, Busch MP. Quantitation of genomic DNA in plasma and serum samples: higher concentrations of genomic DNA found in serum than in plasma. Transfusion 2001; 41: 276-82 (Pubitemid 32220522)
23. Gahan PB, Swaminathan R. Circulating nucleic acids in plasma and serum. Recent developments. Ann NY Acad Sci 2008; 1137: 1-6
24. Kuroi K, Tanaka C, Toi M. Clinical significance of plasma nucleosome levels in cancer patients. Int J Oncol 2001; 19: 143-8
25. Kuroi K, Tanaka C, Toi M. Plasma nucleosome levels in node-negative breast cancer patients. Breast Cancer 1999; 6: 361-4
26. Roth C, Pantel K, Muller V, et al. Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression. BMC Cancer 2010; 11: 4
27. Holdenrieder S, Stieber P, Bodenmuller H, et al. Nucleosomes in serum of patients with benign and malignant diseases. Int J Cancer 2001; 95: 114-20 (Pubitemid 32187083)
28. Kumar S, Guleria R, Singh V, et al. Plasma nucleosome levels might predict response to therapy in patients with advanced non-small-cell lung cancer. Clin Lung Cancer 2010; 11: 36-44
29. Trejo-Becerril C, Perez-Cardenas E, Trevino-Cuevas H, et al. Circulating nucleosomes and response to chemotherapy: an in vitro, in vivo and clinical study on cervical cancer patients. Int J Cancer 2003; 104: 663-8 (Pubitemid 36418501)
30. Lamkanfi M, Kanneganti TD. Caspase-7: a protease involved in apoptosis and inflammation. Int J Biochem Cell Biol 2010; 42: 21-4
31. Soini Y, Paakko P, Lehto VP. Histopathological evaluation of apoptosis in cancer. Am J Pathol 1998; 153: 1041-53 (Pubitemid 28465828)
32. Vakkala M, Paakko P, Soini Y. Expression of caspases 3, 6 and 8 is increased in parallel with apoptosis and histological aggressiveness of the breast lesion. Br J Cancer 1999; 81: 592-9 (Pubitemid 29458853)
33. Deligezer U, Erten N, Akisik EE, Dalay N. Circulating fragmented nucleosomal DNA and caspase-3 mrna in patients with lymphoma and myeloma. Exp Mol Pathol 2006; 80: 72-6 (Pubitemid 41828229)
34. Mandal D, Mazumder A, Das P, et al. Fas-, caspase 8-, and caspase 3-dependent signaling regulates the activity of the aminophospholipid translocase and phosphatidylserine externalization in human erythrocytes. J Biol Chem 2005; 280: 39460-7 (Pubitemid 41713903)
35. Mandal D, Moitra PK, Saha S, Basu J. Caspase 3 regulates phosphatidylserine externalization and phagocytosis of oxidatively stressed erythrocytes. FEBS Lett 2002; 513: 184-8 (Pubitemid 34251261)
36. Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009; 9: 239-52
37. Friedl P, Wolf K. Tube travel: the role of proteases in individual and collective cancer cell invasion. Cancer Res 2008; 68: 7247-9
38. Aimes RT, Zijlstra A, Hooper JD, et al. Endothelial cell serine proteases expressed during vascular morphogenesis and angiogenesis. Thromb Haemost 2003; 89: 561-72 (Pubitemid 36329249)
39. Clark IM, Swingler TE, Sampieri CL, Edwards DR. The regulation of matrix metalloproteinases and their inhibitors. Int J Biochem Cell Biol 2008; 40: 1362-78
40. Hemsen A, Riethdorf L, Brunner N, et al. Comparative evaluation of urokinase-type plasminogen activator receptor expression in primary breast carcinomas and on metastatic tumor cells. Int J Cancer 2003; 107: 903-9 (Pubitemid 37429831)
41. Wu ZS, Wu Q, Yang JH, et al. Prognostic significance of mmp-9 and timp-1 serum and tissue expression in breast cancer. Int J Cancer 2008; 122: 2050-6 (Pubitemid 351441195)
42. Graves LE, Ariztia EV, Navari JR, et al. Proinvasive properties of ovarian cancer ascites-derived membrane vesicles. Cancer Res 2004; 64: 7045-9 (Pubitemid 39331015)
43. Hayes DF, Cristofanilli M, Budd GT, et al. Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin Cancer Res 2006; 12: 4218-24
44. Butler TP, Gullino PM. Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. Cancer Res 1975; 35: 512-16
45. Wong CW, Lee A, Shientag L, et al. Apoptosis: an early event in metastatic inefficiency. Cancer Res 2001; 61: 333-8 (Pubitemid 32095735)
46. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002; 2: 563-72 (Pubitemid 37328923)
47. Schwarzenbach H, Pantel K, Kemper B, et al. Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer. Breast Cancer Res 2009; 11: R71
48. Koyanagi K, Mori T, O'Day SJ, et al. Association of circulating tumor cells with serum tumor-related methylated DNA in peripheral blood of melanoma patients. Cancer Res 2006; 66: 6111-17
49. Matuschek C, Bolke E, Lammering G, et al. Methylated apc and gstp1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease. Eur J Med Res 2010; 15: 277-86
50. Shaw JA, Brown J, Coombes RC, et al. Circulating tumor cells and plasma DNA analysis in patients with indeterminate early or metastatic breast cancer. Biomark Med 2011; 5: 87-91
51. Van der Auwera I, Elst HJ, Van Laere SJ, et al. The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients. Br J Cancer 2009; 100: 1277-86
52. Nawroz-Danish H, Eisenberger CF, Yoo GH, et al. Microsatellite analysis of serum DNA in patients with head and neck cancer. Int J Cancer 2004; 111: 96-100 (Pubitemid 38859289)